Two periods of 90 days of trimetazidine (60 mg/day) also increased cardiac phosphocreatine/ATP ratio in nine patients (but three patients showed a decrease), which indicated improved mitochondrial energetics [146]
Desmet J, van Dael H, van Cauwelaert F, Nitta K, Sugai S: Comparison of the binding of Ca 2+ and Mn 2+ to bovine -lactalbumin and equine lysozyme
06 Confusion between routes Subcutaneous, oral, transdermal, and intranasal AOD-9604 use very different doses
A Self-Assessment Framework Rather than making outcome claims, the most useful framing for a research-stage category is a self-qualification exercise
A fair comparison would require same-duration data, which does not exist for monotherapy
Weeks 25-48: Maintenance Optimization Later treatment phases involve continued improvement at diminishing rates